PharSafer
PharSafer is a UK-founded specialist CRO providing end-to-end pharmacovigilance, regulatory strategy, auditing, and medical affairs services to pharmaceutical, biotech, ATMP, device, and cosmetics clients across 130+ countries via its proprietary R.A.P.T.A.R. automation platform.
- Company typePrivate
- Founded2003
- HeadquartersWisley, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingServices
What PharSafer does
PharSafer Associates Limited is a privately held specialist Contract Research Organisation (CRO) founded in 2003 by Dr. Graeme Ladds and headquartered in Ripley, Surrey, UK. The company delivers end-to-end pharmacovigilance and medical services to pharmaceutical, biotech, ATMP, medical device, and cosmetics organisations across 130+ countries, operating as an outsourced drug safety department for its clients. Its service portfolio spans six departments — Pharmacovigilance, Regulatory Strategy, SaPhar Training, White Gloves Audit Group, Medical Affairs, and Informatics — covering ICSR processing, aggregate reporting, signal detection, risk management, regulatory submissions, GCP/GPvP auditing, medical information, and database management.
The technology backbone is R.A.P.T.A.R., a proprietary safety automation and workflow platform comprising Reader, Clinical, and Reporting modules that support compliant, inspection-ready case processing for drugs, devices, vaccines, cosmetics, and drug-device combinations. Cumulative operating scale includes 750,000+ processed cases, 175+ audits, 97-99% case accuracy, and a validated global safety database. The company is wholly founder-owned (no external institutional investors disclosed), employs 101-250 people, and operates from the UK, India, Spain, and a remote US sales presence.
Revenue is generated exclusively through bespoke enterprise professional services engagements, with pricing not publicly disclosed. PharSafer pursues enterprise clients through dedicated New Business Managers in India and the US, RFP submission, introductory meetings, and conference-led thought leadership (BIO, DIA, World Drug Safety Congress). The company claims majority of clients have been retained 10+ years and 70% of clients reside outside the UK, indicating international revenue diversification and sticky, long-tail relationships.
PharSafer firmographics
Firmographics- Name
- PharSafer
- Legal name
- PharSafer Associates Limited
- Website
- https://pharsafer.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PharSafer is a UK-founded specialist CRO providing end-to-end pharmacovigilance, regulatory strategy, auditing, and medical affairs services to pharmaceutical, biotech, ATMP, device, and cosmetics clients across 130+ countries via its proprietary R.A.P.T.A.R. automation platform.
- Ownership category
- akta.pro rank
PharSafer industry classification
Industry- Product category
- Pharmacovigilance and Drug Safety Services
- NAICS
- Scientific Research and Development Services (5417)
- akta.pro primary industry
- Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)
- akta.pro secondary industries
- Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where PharSafer is headquartered
LocationHeadquarters
- HQ city
- Wisley
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
PharSafer business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmacovigilance Services: Full-service pharmacovigilance operations including case processing, ICSR submissions, literature review, signal detection, and aggregate reporting. Services are delivered as a complete outsourced pharmacovigilance department for clients.
- Regulatory Strategy Services: Strategic consulting for license submissions, scientific advice, and regulatory pathway optimization across global markets including EU, UK, US, and emerging regions.
- Auditing Services: GCP and GPvP auditing services including gap-fill analysis, pre-qualification assessments, and inspection readiness support through the White Gloves Audit Group.
- Medical Affairs Services: Medical information services, safety communications, and medical review support for pharmaceutical and biotech products.
- Training Services (SaPhar): Industry training services delivered through sister company SaPhar for pharmacovigilance and clinical professionals, including new training courses and certification programs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
PharSafer product offering
Product offeringCore offering
PharSafer is a specialist Contract Research Organisation (CRO) that delivers full-service pharmacovigilance and medical services, including ICSR processing, aggregate reporting, signal detection, risk management plans, regulatory strategy, auditing, medical affairs, informatics, and industry training. Service delivery is enabled by R.A.P.T.A.R., a proprietary safety automation and workflow platform, supported by a validated global safety database and 24/5 operations across the UK, India, and Spain for clinical and post-marketing drug safety.
Product overview
PharSafer® is a specialist Contract Research Organisation (CRO) offering Global Clinical and Post Marketing Drug Safety and Medical Services through a multi-department structure. The core product is R.A.P.T.A.R.® — a proprietary safety automation and workflow platform supporting compliant, inspection-ready case processing across drugs, devices, vaccines, cosmetics, and drug-device combinations. R.A.P.T.A.R.® Reader and R.A.P.T.A.R.® Clinical are sub-modules of this platform. These technology offerings are complemented by six service departments: Pharmacovigilance Services (ICSR processing, aggregate reporting, signal detection), Regulatory Strategy, SaPhar Training, White Gloves Audit Group, Medical Affairs, and Informatics. Together, the R.A.P.T.A.R.® platform and service departments enable PharSafer to operate as a client's complete Pharmacovigilance & Medical Services department.
Differentiator
Problem solved
Functional benefit
Brands
- RAPTAR®: Proprietary pharmacovigilance reporting and automation platform supporting compliant, inspection-ready safety processes.
- SaPhar
- White Gloves Audit Group
Products and services
- R.A.P.T.A.R. (Reporting, Analysis, Pharmacovigilance Tracking, Automation & Reporting) A proprietary safety automation and workflow platform supporting compliant, inspection-ready pharmacovigilance case processing, signal detection, and adverse event reporting across drugs, devices, vaccines, cosmetics, and drug-device combinations. Includes the Reporting, Clinical, and Reader modules with access controls, auditability, workflow structures supporting data minimisation, and secure handling of safety data.
- Pharmacovigilance Services Full-service pharmacovigilance support including ICSR processing, literature review, aggregate reporting (PSURs/PBRERs/DSURs), signal detection, risk management plans (RMPs/REMs), safety narrative generation, SOP writing, and case quality assurance for clinical and post-marketing phases. Delivered as a complete outsourced pharmacovigilance department for pharmaceutical, biotech, medical device, and cosmetics clients.
- Regulatory Strategy Strategic regulatory consulting covering clinical data submissions, license applications, scientific advice, and compliance pathway optimisation across global markets including the EU, UK, US, and emerging regions.
- SaPhar Training Industry-focused pharmacovigilance and clinical training programs delivered by PharSafer's sister company SaPhar, serving as the training platform for all PharSafer employee and client training on pharmacovigilance and clinical topics.
- White Gloves Audit Group Specialist auditing services including GCP and GPvP audits, gap-fill analysis, pre-qualification assessments, and inspection readiness support to help clients prepare for regulatory inspections.
- Medical Affairs Medical information services, safety communications, medical review, and scientific support for effective and proper product usage communication for pharmaceutical and biotech clients.
- Informatics Pharmacovigilance database management, safety database migration, ICSR processing tools, and systems support for global patient safety operations.
Quantifiable outcome
- 97-99% case accuracy and compliance achieved on all cases
- +3 more outcomes
Companies that use PharSafer
Customer profileSegments5 records
Ideal customer profiles4 records
PharSafer technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
PharSafer partnerships and signals
Strategic signalScale indicators9 records
Recent moves8 records
Expansion highlights5 records
PharSafer competitors and assessment
Company assessmentBroad incumbents
- ICON plc: Large full-service CRO with established post-marketing pharmacovigilance capabilities post-PRA Health Sciences acquisition. Competes with PharSafer in mid-to-large pharma PV outsourcing.
- Parexel International: Global full-service CRO with significant pharmacovigilance and regulatory services. Represents the broader incumbent alternative to PharSafer's specialist positioning.
- IQVIA: Largest global CRO with comprehensive pharmacovigilance offerings as part of its broader life sciences services. Competes with PharSafer for enterprise pharma PV contracts at the high end.
- Worldwide Clinical Trials: Mid-to-large full-service CRO with established pharmacovigilance and medical affairs capabilities. Broader portfolio than PharSafer but competes for the same outsourced PV mandates.
Direct peers
- Pharmalex: Regulatory affairs and pharmacovigilance services provider with strong European footprint. Comparable to PharSafer in PV/regulatory focus and similar mid-tier client segment.
- PrimeVigilance: Specialist pharmacovigilance CRO offering case processing, signal management, and aggregate reporting to pharma/biotech. Closest direct competitor to PharSafer in the dedicated mid-size PV services segment.
- Ergomed plc: Specialized CRO with both clinical research and pharmacovigilance service lines. Direct overlap with PharSafer on the PV side, with additional clinical CRO breadth.
- Arriello: Drug safety, regulatory affairs, and quality/compliance consultancy serving pharma and biotech with similar mid-size CRO economics. Comparable in service mix and target customer profile.
- Navitas Life Sciences: Pharmacovigilance and regulatory services provider with global delivery capability. Overlaps with PharSafer on PV case processing, aggregate reporting, and safety database services.
- ProPharma Group: Provides pharmacovigilance, regulatory affairs, and compliance consulting to pharma, biotech, and medical device companies. Overlaps directly with PharSafer's PV, regulatory strategy, and auditing offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PharSafer social profiles
Digital presencePharSafer financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharSafer leadership team
Management profileNumber of profiles
Profiles1 record
PharSafer subsidiaries and ownership
Company hierarchySubsidiaries1 record
PharSafer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharSafer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharSafer
What does PharSafer do?
PharSafer is a specialist Contract Research Organisation (CRO) that delivers full-service pharmacovigilance and medical services, including ICSR processing, aggregate reporting, signal detection, risk management plans, regulatory strategy, auditing, medical affairs, informatics, and industry training. Service delivery is enabled by R.A.P.T.A.R., a proprietary safety automation and workflow platform, supported by a validated global safety database and 24/5 operations across the UK, India, and Spain for clinical and post-marketing drug safety.
Is PharSafer a public or private company?
PharSafer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PharSafer founded?
PharSafer was founded in 2003. It employs 101 to 250 people.
Where is PharSafer based?
PharSafer is headquartered in Wisley, United Kingdom, in the Europe region.
How does PharSafer make money?
Five revenue lines are on record. Pharmacovigilance Services are the primary driver. The others are regulatory Strategy Services, auditing Services, medical Affairs Services and training Services (SaPhar).
Who are PharSafer's main competitors?
Broad incumbents on record are ICON plc, Parexel International, IQVIA and Worldwide Clinical Trials. Direct peers are Pharmalex, PrimeVigilance, Ergomed plc, Arriello, Navitas Life Sciences and ProPharma Group.
Does PharSafer have an API?
No public API is recorded for PharSafer.
What industry is PharSafer in?
PharSafer's product category is Pharmacovigilance and Drug Safety Services. Its primary akta.pro industry code is HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs, with a secondary code of HLAGAAAG, Medical Writing & Regulatory Submission Support CROs. Its NAICS code is 5417.